Thus, we uncover a role of YAP in regulation of the NLRP3 inflammasome activation, and provide potential therapeutic target to treat a number of inflammatory disorders, such as atherosclerosis, gout, colitis, and sepsis. The gene discussed is YAP1; the disease is gout.